Robert Ticktin
Fortuna: 119 421 $ al 31/08/2026
Fortuna: 119 421 $ al 31/08/2026
Mr. Robert Ticktin is a COO, Secretary & General Counsel at PMV Pharmaceuticals, Inc. Mr. Ticktin was previously employed as an Associate General Counsel by Tesaro, Inc., a Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc. /Old/, a Secretary, Senior Vice President & General Counsel by EPIRUS Biopharmaceuticals, Inc., and a Senior Vice President & General Counsel by Zalicus, Inc. He received his undergraduate degree from The Ohio State University and a graduate degree from Fordham University School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 07/04/2026 | 98.695 ( 0,18 % ) | 119 421 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director de Operaciones | 01/12/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01/06/2020 |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Consejero General | 01/08/2016 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Consejero General | - |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for cancer patients | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zalicus, Inc.
Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Health Technology |
Fordham University School of Law
Fordham University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EPIRUS Biopharmaceuticals, Inc.
EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.